?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
August 12, 2021
signalgroup
President Biden’s Plan to Lower Drug Prices Highlights Need for Competition from Biosimilars
News
August 11, 2021
signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Organon
News
July 29, 2021
signalgroup
FDA’s Approval of First Interchangeable Biosimilar Product Paves Way for Lower Health Care Costs for Patients
News
July 15, 2021
signalgroup
Food & Drug Administration Takes Strong Enforcement Action Against Biosimilar Misinformation
News
July 9, 2021
signalgroup
President Biden’s Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients
News
July 8, 2021
signalgroup
Morning Consult: Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate
News
June 30, 2021
signalgroup
Biosimilars Forum Member Spotlight: 6 Questions for Coherus
News
June 24, 2021
signalgroup
Organon Joins Biosimilars Forum
News
June 21, 2021
signalgroup
Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up
News
June 18, 2021
signalgroup
It’s time we fulfill the ACA’s promise to broaden access to lower-cost drugs
Prev page
06
07
08
09
10
Next page